VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
495
New
Increased
Reduced
Closed

Top Buys

1
+$2.11M
2
+$2.09M
3
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

1
+$2.13M
2
+$2.13M
3
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
151
Krystal Biotech
KRYS
$9.11B
$891K 0.25%
3,449
+657
LGND icon
152
Ligand Pharmaceuticals
LGND
$4.65B
$889K 0.25%
4,453
+848
BIIB icon
153
Biogen
BIIB
$28.9B
$889K 0.25%
4,848
+925
EXEL icon
154
Exelixis
EXEL
$12.7B
$886K 0.24%
20,651
+3,935
PSEC icon
155
Prospect Capital
PSEC
$1.21B
$882K 0.24%
337,946
-122,843
HALO icon
156
Halozyme
HALO
$7.89B
$877K 0.24%
13,571
+2,587
ASND icon
157
Ascendis Pharma A/S
ASND
$13.8B
$876K 0.24%
3,830
+730
SRPT icon
158
Sarepta Therapeutics
SRPT
$1.89B
$853K 0.24%
39,213
+7,472
BBIO icon
159
BridgeBio Pharma
BBIO
$13B
$834K 0.23%
11,234
+2,141
ARDX icon
160
Ardelyx
ARDX
$1.49B
$814K 0.22%
135,954
+25,906
BNTX icon
161
BioNTech
BNTX
$24.3B
$791K 0.22%
8,904
+1,697
AUPH icon
162
Aurinia Pharmaceuticals
AUPH
$1.97B
$789K 0.22%
53,267
+10,150
GSBD icon
163
Goldman Sachs BDC
GSBD
$1.01B
$788K 0.22%
88,738
-11,151
ONC
164
BeOne Medicines Ltd
ONC
$29.9B
$786K 0.22%
2,646
+505
IONS icon
165
Ionis Pharmaceuticals
IONS
$12.6B
$784K 0.22%
10,445
+1,991
MDGL icon
166
Madrigal Pharmaceuticals
MDGL
$11.5B
$773K 0.21%
1,476
+282
PTCT icon
167
PTC Therapeutics
PTCT
$6.13B
$760K 0.21%
11,160
+2,127
ARWR icon
168
Arrowhead Research
ARWR
$11B
$755K 0.21%
12,045
+2,296
TBPH icon
169
Theravance Biopharma
TBPH
$828M
$754K 0.21%
46,464
+8,853
PNNT
170
Pennant Park Investment Corp
PNNT
$255M
$743K 0.21%
165,540
+42,374
FSK icon
171
FS KKR Capital
FSK
$3.04B
$735K 0.2%
72,227
+9,306
OCSL icon
172
Oaktree Specialty Lending
OCSL
$1.05B
$730K 0.2%
64,582
+103
TARS icon
173
Tarsus Pharmaceuticals
TARS
$2.56B
$728K 0.2%
10,378
+1,979
NBIX icon
174
Neurocrine Biosciences
NBIX
$15.9B
$728K 0.2%
5,524
+1,052
TVTX icon
175
Travere Therapeutics
TVTX
$4.39B
$720K 0.2%
24,239
+4,619
5 6
7
8 9